Kiora Capital Stock from 2010 to 2025

KPRX Stock

USD 3.25 0.10 2.99%

Kiora Pharmaceuticals Capital Stock yearly trend continues to be fairly stable with very little volatility. Capital Stock is likely to outpace its year average in 2025. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals

Capital Stock

First Reported

2010-12-31

Previous Quarter

69.4 K

Current Value

100.8 K

Quarterly Volatility

190.1 K

Credit Downgrade

Yuan Drop

Covid

Check Kiora Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kiora Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 84.2 K, Selling General Administrative of 4.8 M or Other Operating Expenses of 10.3 M, as well as many indicators such as Price To Sales Ratio of 16 K, Dividend Yield of 0.0 or PTB Ratio of 0.39. Kiora financial statements analysis is a perfect complement when working with Kiora Pharmaceuticals Valuation or Volatility modules.

Check out the analysis of Kiora Pharmaceuticals Correlation against competitors.

For more information on how to buy Kiora Stock please use our How to Invest in Kiora Pharmaceuticals guide.

Latest Kiora Pharmaceuticals' Capital Stock Growth Pattern

Below is the plot of the Capital Stock of Kiora Pharmaceuticals over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. Kiora Pharmaceuticals' Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kiora Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

Capital Stock

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Capital Stock

Timeline

Kiora Capital Stock Regression Statistics

	Arithmetic Mean	276,884
	Geometric Mean	183,502
	Coefficient Of Variation	68.64
	Mean Deviation	181,233
	Median	437,980
	Standard Deviation	190,060
	Sample Variance	36.1B
	Range	420K
	R-Value	(0.84)
	Mean Square Error	11.2B
	R-Squared	0.71
	Significance	0.000041
	Slope	(33,650)
	Total Sum of Squares	541.8B

Kiora Capital Stock History

	2025	100.8 K
	2024	69.4 K
	2023	77.1 K
	2022	18 K
	2021	126.6 K
	2020	55.6 K
	2019	40.8 K

Other Fundumenentals of Kiora Pharmaceuticals

Issuance Of Capital Stock

Kiora Pharmaceuticals Capital Stock component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Current Deferred Revenue	Intangible Assets	Net Tangible Assets	Deferred Long Term Liab	Net Invested Capital	Net Working Capital	Property Plant Equipment	Capital Stock	Long Term Debt	Short Long Term Debt
Total Assets		0.93	-0.63	-0.86	0.28	0.47	-0.88	0.75	-0.49	0.48	0.46	0.64	0.76	0.71	0.8	0.78	0.56	-0.68	-0.18	-0.18
Total Stockholder Equity	0.93		-0.65	-0.81	0.28	0.49	-0.99	0.76	-0.56	0.5	0.41	0.46	0.72	0.56	0.74	0.73	0.46	-0.65	-0.25	-0.25
Net Debt	-0.63	-0.65		0.28	-0.16	-0.04	0.65	-0.94	0.65	-0.6	-0.45	0.02	-0.23	-0.02	-0.3	-0.34	-0.1	0.04	-0.13	-0.13
Retained Earnings	-0.86	-0.81	0.28		-0.11	-0.75	0.74	-0.49	0.35	-0.26	-0.31	-0.75	-0.92	-0.81	-0.85	-0.85	-0.81	0.87	0.46	0.46
Accounts Payable	0.28	0.28	-0.16	-0.11		-0.04	-0.27	0.17	-0.01	-0.05	0.38	0.15	-0.14	0.02	-0.07	-0.16	-0.02	0.0	0.14	0.14
Net Receivables	0.47	0.49	-0.04	-0.75	-0.04		-0.43	0.32	-0.25	-0.01	0.08	0.67	0.72	0.65	0.5	0.51	0.89	-0.61	-0.72	-0.72
Total Liab	-0.88	-0.99	0.65	0.74	-0.27	-0.43		-0.74	0.56	-0.49	-0.34	-0.38	-0.65	-0.49	-0.68	-0.68	-0.37	0.61	0.17	0.17
Total Current Assets	0.75	0.76	-0.94	-0.49	0.17	0.32	-0.74		-0.53	0.61	0.48	0.17	0.44	0.2	0.44	0.49	0.36	-0.2	-0.09	-0.09
Short Term Debt	-0.49	-0.56	0.65	0.35	-0.01	-0.25	0.56	-0.53		-0.3	-0.29	-0.16	-0.31	-0.21	-0.3	-0.31	-0.2	0.26	0.14	0.14
Common Stock	0.48	0.5	-0.6	-0.26	-0.05	-0.01	-0.49	0.61	-0.3		0.37	-0.18	0.33	-0.04	0.37	0.4	0.0	0.1	-0.05	-0.05
Current Deferred Revenue	0.46	0.41	-0.45	-0.31	0.38	0.08	-0.34	0.48	-0.29	0.37		0.02	0.05	0.01	0.01	0.01	0.08	-0.02	-0.17	-0.17
Intangible Assets	0.64	0.46	0.02	-0.75	0.15	0.67	-0.38	0.17	-0.16	-0.18	0.02		0.66	0.96	0.63	0.57	0.77	-0.76	-0.31	-0.31
Net Tangible Assets	0.76	0.72	-0.23	-0.92	-0.14	0.72	-0.65	0.44	-0.31	0.33	0.05	0.66		0.76	0.94	0.96	0.8	-0.84	-0.51	-0.51
Deferred Long Term Liab	0.71	0.56	-0.02	-0.81	0.02	0.65	-0.49	0.2	-0.21	-0.04	0.01	0.96	0.76		0.73	0.7	0.74	-0.83	-0.3	-0.3
Net Invested Capital	0.8	0.74	-0.3	-0.85	-0.07	0.5	-0.68	0.44	-0.3	0.37	0.01	0.63	0.94	0.73		0.97	0.62	-0.84	-0.3	-0.3
Net Working Capital	0.78	0.73	-0.34	-0.85	-0.16	0.51	-0.68	0.49	-0.31	0.4	0.01	0.57	0.96	0.7	0.97		0.66	-0.8	-0.3	-0.3
Property Plant Equipment	0.56	0.46	-0.1	-0.81	-0.02	0.89	-0.37	0.36	-0.2	0.0	0.08	0.77	0.8	0.74	0.62	0.66		-0.66	-0.62	-0.62
Capital Stock	-0.68	-0.65	0.04	0.87	0.0	-0.61	0.61	-0.2	0.26	0.1	-0.02	-0.76	-0.84	-0.83	-0.84	-0.8	-0.66		0.36	0.36
Long Term Debt	-0.18	-0.25	-0.13	0.46	0.14	-0.72	0.17	-0.09	0.14	-0.05	-0.17	-0.31	-0.51	-0.3	-0.3	-0.3	-0.62	0.36		1.0
Short Long Term Debt	-0.18	-0.25	-0.13	0.46	0.14	-0.72	0.17	-0.09	0.14	-0.05	-0.17	-0.31	-0.51	-0.3	-0.3	-0.3	-0.62	0.36	1.0

Click cells to compare fundamentals

About Kiora Pharmaceuticals Financial Statements

Kiora Pharmaceuticals investors use historical fundamental indicators, such as Kiora Pharmaceuticals' Capital Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kiora Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Capital Stock	69.4 K	100.8 K
Issuance Of Capital Stock	7.4 M	8.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for Kiora Stock Analysis

When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Kiora Capital Stock from 2010 to 2025

Latest Kiora Pharmaceuticals' Capital Stock Growth Pattern

Kiora Capital Stock Regression Statistics

Kiora Capital Stock History

Other Fundumenentals of Kiora Pharmaceuticals

Kiora Pharmaceuticals Capital Stock component correlations

About Kiora Pharmaceuticals Financial Statements

Also Currently Popular

Additional Tools for Kiora Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY